Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab
We report a patient with macular oedema due to type 1 macular telangiectasia responding to intravitreal aflibercept injection. A 51-year-old man was diagnosed with type 1 idiopathic macular telangiectasia (IMT) in the right eye. The macular oedema was refractory to initial treatment with intravitrea...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Case Reports in Ophthalmological Medicine |
| Online Access: | http://dx.doi.org/10.1155/2014/219792 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832565574744408064 |
|---|---|
| author | O’Sam Shibeeb Anagha Vaze Mark Gillies Timothy Gray |
| author_facet | O’Sam Shibeeb Anagha Vaze Mark Gillies Timothy Gray |
| author_sort | O’Sam Shibeeb |
| collection | DOAJ |
| description | We report a patient with macular oedema due to type 1 macular telangiectasia responding to intravitreal aflibercept injection. A 51-year-old man was diagnosed with type 1 idiopathic macular telangiectasia (IMT) in the right eye. The macular oedema was refractory to initial treatment with intravitreal bevacizumab and argon laser photocoagulation. The patient was then treated with intravitreal aflibercept injections, following which the macular oedema was completely resolved and his vision was significantly improved. Intravitreal aflibercept injection appears to improve vision and reduce persistent macular oedema secondary to type 1 IMT and demonstrated promising anatomical and visual outcomes. |
| format | Article |
| id | doaj-art-3a9ad97aaa5a4fce9828a70a4fd0fc7f |
| institution | Kabale University |
| issn | 2090-6722 2090-6730 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Ophthalmological Medicine |
| spelling | doaj-art-3a9ad97aaa5a4fce9828a70a4fd0fc7f2025-02-03T01:07:17ZengWileyCase Reports in Ophthalmological Medicine2090-67222090-67302014-01-01201410.1155/2014/219792219792Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not BevacizumabO’Sam Shibeeb0Anagha Vaze1Mark Gillies2Timothy Gray3Ophthalmic Research Laboratories, South Australian Institute of Ophthalmology, Hanson Institute Centre for Neurological Diseases, University of Adelaide, Frome Road, Adelaide, SA 5000, AustraliaDepartment of Ophthalmology and Visual Sciences, Royal Adelaide Hospital, Frome Road, Adelaide, SA 5000, AustraliaSave Sight Institute, The University of Sydney, Sydney, NSW 2006, AustraliaDepartment of Ophthalmology and Visual Sciences, Royal Adelaide Hospital, Frome Road, Adelaide, SA 5000, AustraliaWe report a patient with macular oedema due to type 1 macular telangiectasia responding to intravitreal aflibercept injection. A 51-year-old man was diagnosed with type 1 idiopathic macular telangiectasia (IMT) in the right eye. The macular oedema was refractory to initial treatment with intravitreal bevacizumab and argon laser photocoagulation. The patient was then treated with intravitreal aflibercept injections, following which the macular oedema was completely resolved and his vision was significantly improved. Intravitreal aflibercept injection appears to improve vision and reduce persistent macular oedema secondary to type 1 IMT and demonstrated promising anatomical and visual outcomes.http://dx.doi.org/10.1155/2014/219792 |
| spellingShingle | O’Sam Shibeeb Anagha Vaze Mark Gillies Timothy Gray Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab Case Reports in Ophthalmological Medicine |
| title | Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab |
| title_full | Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab |
| title_fullStr | Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab |
| title_full_unstemmed | Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab |
| title_short | Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab |
| title_sort | macular oedema in idiopathic macular telangiectasia type 1 responsive to aflibercept but not bevacizumab |
| url | http://dx.doi.org/10.1155/2014/219792 |
| work_keys_str_mv | AT osamshibeeb macularoedemainidiopathicmaculartelangiectasiatype1responsivetoafliberceptbutnotbevacizumab AT anaghavaze macularoedemainidiopathicmaculartelangiectasiatype1responsivetoafliberceptbutnotbevacizumab AT markgillies macularoedemainidiopathicmaculartelangiectasiatype1responsivetoafliberceptbutnotbevacizumab AT timothygray macularoedemainidiopathicmaculartelangiectasiatype1responsivetoafliberceptbutnotbevacizumab |